MX346466B - Comprimido de tipo liberacion controlada que contiene aceclofenaco. - Google Patents

Comprimido de tipo liberacion controlada que contiene aceclofenaco.

Info

Publication number
MX346466B
MX346466B MX2013011891A MX2013011891A MX346466B MX 346466 B MX346466 B MX 346466B MX 2013011891 A MX2013011891 A MX 2013011891A MX 2013011891 A MX2013011891 A MX 2013011891A MX 346466 B MX346466 B MX 346466B
Authority
MX
Mexico
Prior art keywords
controlled release
release type
type tablet
tablet containing
tablet
Prior art date
Application number
MX2013011891A
Other languages
English (en)
Spanish (es)
Other versions
MX2013011891A (es
Inventor
Auh Jin
Han Chang-Kyun
Jeong Hyeon-Gun
Kim Yang-Joong
Kim Jong-Geal
Lee Jung-Hwa
Ha Nam-Sung
Original Assignee
Ahn-Gook Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ahn-Gook Pharmaceutical Co Ltd filed Critical Ahn-Gook Pharmaceutical Co Ltd
Publication of MX2013011891A publication Critical patent/MX2013011891A/es
Publication of MX346466B publication Critical patent/MX346466B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MX2013011891A 2011-04-13 2012-04-12 Comprimido de tipo liberacion controlada que contiene aceclofenaco. MX346466B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110034022A KR101310099B1 (ko) 2011-04-13 2011-04-13 아세클로페낙 함유 방출제어형 정제
PCT/KR2012/002769 WO2012141502A2 (fr) 2011-04-13 2012-04-12 Comprimé de type à libération prolongée contenant de l'aceclofénac

Publications (2)

Publication Number Publication Date
MX2013011891A MX2013011891A (es) 2014-03-31
MX346466B true MX346466B (es) 2017-03-22

Family

ID=47009839

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013011891A MX346466B (es) 2011-04-13 2012-04-12 Comprimido de tipo liberacion controlada que contiene aceclofenaco.

Country Status (4)

Country Link
KR (1) KR101310099B1 (fr)
BR (1) BR112013026473B1 (fr)
MX (1) MX346466B (fr)
WO (1) WO2012141502A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102236650B1 (ko) * 2019-04-16 2021-04-07 한국유나이티드제약 주식회사 아세클로페낙을 포함하는 약학조성물 및 이의 제조방법
KR102426727B1 (ko) 2020-04-17 2022-07-28 성균관대학교산학협력단 방출 속도 조절 경구용 약물 전달 장치 및 방출 속도 조절 경구용 약물 전달 장치의 제조 방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1277550A (zh) 1997-09-11 2000-12-20 尼科梅德丹麦有限公司 非甾体抗炎药物(NSAIDs)的改进释放的复合型组合物
KR100504013B1 (ko) * 2003-02-28 2005-07-28 한국유나이티드제약 주식회사 제어방출형 경구 펠렛제제 및 그 제조방법
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
US20070092573A1 (en) * 2005-10-24 2007-04-26 Laxminarayan Joshi Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
KR100911517B1 (ko) * 2007-08-31 2009-08-10 주식회사 드림파마 신규한 서방출형 아세클로페낙 제제 조성물 및 그의제조방법
KR101076648B1 (ko) * 2008-12-04 2011-10-26 한국유나이티드제약 주식회사 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법

Also Published As

Publication number Publication date
WO2012141502A3 (fr) 2013-01-03
KR20120116545A (ko) 2012-10-23
BR112013026473B1 (pt) 2021-10-13
BR112013026473A8 (pt) 2018-01-30
MX2013011891A (es) 2014-03-31
WO2012141502A2 (fr) 2012-10-18
KR101310099B1 (ko) 2013-09-23
BR112013026473A2 (pt) 2016-12-20

Similar Documents

Publication Publication Date Title
MX350875B (es) Formas de dosificacion farmaceutica de liberacion controlada.
IL239325A0 (en) An oral dosage form that includes crush-resistant coated particles for immediate release of at least one active compound
IL234815A0 (en) Heat-manufactured unbreakable pharmaceutical dosage form containing zinc
EP4249055A3 (fr) Formes pharmaceutiques orales de tofacitinib à libération prolongée
ZA201304634B (en) Polymeric matrix of polymer-lipid nanoparticles as a pharmaceutical dosage form
HUE057510T2 (hu) Félplasztikus gyógyszerészeti dózisegységek elõállítása
HK1191572A1 (en) Coating composition suitable for pharmaceutical or nutraceutical dosage forms
IL228397A0 (en) A coating preparation suitable for dosage forms of pharmaceuticals or nutritional supplements
IL229170A0 (en) Preparations in the form of tablets that dissolve quickly for vaginal administration
MX359288B (es) Forma iv del clorhidrato de ivabradina.
IN2015DN04161A (fr)
MX344846B (es) Combinacion de granulos cargados activos con activos adicionales.
PH12014501408A1 (en) Immediate release multi unit pellet system
CA2863376A1 (fr) Comprimes gastro-resistants
ZA201302012B (en) Low dose pharmaceutical composition
WO2012074830A3 (fr) Formulation d'acide tranexamique à libération modifiée
MX2013011891A (es) Comprimido de tipo liberacion controlada que contiene aceclofenaco.
IL236466A0 (en) Pharmaceutical composition for the release of active components
PL2874908T3 (pl) Opakowanie na dozowane pojedynczo, zawierające substancję czynną listki oraz sposób wytwarzania tego opakowania
PH12014502325A1 (en) Sustained release tablet containing levodropropizine and method for preparing same
IL239670B (en) Monolithic administration form for delayed release of a combination of active substances
EP2879663C0 (fr) Pastilles a cinetiques multiples de liberation de principes actifs
WO2014013090A3 (fr) Formulation comprenant du fingolimod amorphe
EP2883546A4 (fr) Nouvelle composition pharmaceutique à libération différentielle contenant trois principes actifs
WO2013115736A3 (fr) Formulations pour comprimés bicouches de flurbiprofène et glucosamine

Legal Events

Date Code Title Description
FG Grant or registration